INVENTORY TO THE

RALPH METZNER COLLECTION OF ARTICLES, 1958–2008

Purdue University Libraries Virginia Kelly Karnes Archives and Special Collections

Research Center 504 West State Street

West Lafayette, Indiana 47907-2058 (765) 494-6414

http://www.lib.purdue.edu/spcol

© 2009 Purdue University Libraries. All rights reserved.

Revised: Kristin Leaman, October 2011 Compiled By: Emma C. Meyer, 2009

4/12/2012 2

Descriptive Summary

Creator Information Metzner, Ralph, 1936- Title Ralph Metzner collection of articles Collection Identifier MSP 56 Date Span 1958–2008, predominant 1960s–1990s Abstract This collection contains articles and publications collected by

Ralph Metzner that explore different aspects of the progression of psychoactive substance research, including scientific research, politics, and religion.

Extent 0.6 cubic ft. (2 boxes) Finding Aid Author Emma C. Meyer, 2009 Languages English, German, Portuguese Repository Virginia Kelly Karnes Archives and Special Collections

Research Center, Purdue University Libraries Administrative Information

Location Information: ASC Access Restrictions: Collection is open for research. Acquisition Information: October 2008; Ralph Metzner; donation Preferred Citation: MSP 56, Ralph Metzner collection of articles, Archives and

Special Collections, Purdue University Libraries Copyright Notice: The materials in this collection are protected by copyright.

Permission to publish, quote, or reproduce must be secured from the publisher of the article.

4/12/2012 3

Subjects and Genres Persons Metzner, Ralph, 1936- Topics Ayahuasca Therapeutic Use Ayahuasca Ceremony Cannabis—Law and Legislation Cannabis—Therapeutic use DMT (drug) Drug research perspectives Hallucinogens—Pharmacology Hallucinogenic Plants Ketamine LSD (drug) Ecstasy (drug) Form and Genre Types Articles Books Newspaper Clippings Photocopies Occupations Psychologists Scientists Shamans

4/12/2012 4

Biography of Ralph Metzner

Ralph Metzner was born to Wolfgang and Jill (Laurie) Metzner in Berlin, Germany on May 18, 1936. Metzner moved to the United States in 1958 and became a naturalized citizen in 1968. He earned his baccalaureate degree at Oxford University in 1958, graduating with first class honors. Metzner then continued his studies at Harvard University, earning a doctorate in Clinical Psychology in 1962. While at Harvard, Metzner worked with Timothy Leary and Richard Alpert (who later became Ram Dass) on the Harvard Psilocybin Projects. Metzner writes of this period, “Starting in 1961 I spent six years researching psychedelic drugs as tools for consciousness expansion and personal growth. Since that time I’ve pursued many other paths to greater awareness.” Upon leaving Harvard, Metzner began practicing psychology, first as an intern and then as a staff psychologist. He was employed by various institutions, including Concord State Prison (1961-1963), the Castalia Foundation (1963-1965), Mendocino State Hospital (1967-1968), the Kaiser Permanente Medical Group (1968-1969), and the Fairview State Hospital (1970-1972). In addition, Metzner also founded and directed the Star Mountain School, a high school for emotionally unwell adolescents, from 1972 until 1973. Throughout this period Metzner continued to collaborate with Leary and Alpert, co-authoring The Psychedelic Experience in 1964. He also edited the Psychedelic Review publication from 1965 until 1967, and a book (again working with Leary) entitled The Psychedelic Reader.

In conjunction with his career training, Metzner pursued his search for higher levels of consciousness. One mode of thought he found particularly attractive was Actualism as developed by Russell Schofield. To pursue this further, Metzner enrolled in the School of Actualism in Los Angeles in 1968. By the 1970s, Metzner had deeply immersed himself in the study of Agni Yoga, a meditative system focused on life-energies. He practiced this intensively for a decade, during which time he also returned to the School of Actualism as a staff teacher and completed two books. Maps of Consciousness was published in 1971 as one of the first efforts to comparatively chart states of consciousness. Know Your Type was published in 1978 and provided an assessment of all personal typologies, both ancient and modern.

During the late 1960s, Metzner branched out in a new direction, opening his own private practice as a psychotherapist and consultant in Palo Alto, California. By 1975, Metzner started teaching at California Institute of Integral Studies as an associate professor. In 1979 he became the academic dean, a position which he held until 1988. Currently Metzner is Professor Emeritus at the California Institute of Integral Studies and remains active with the Green Earth Foundation. The Green Earth Foundation, with Metzner as its co-founder and president, is an educational organization that seeks to improve the relationship between humanity and the Earth through research in consciousness studies, shamanism and earth mythology, and ecological studies and eco- or green-psychology.

4/12/2012 5

Collection Description

Scope

The Ralph Metzner collection of articles (1958–2008; 0.6 cubic feet) documents the progression of psychoactive substance research, legality issues, and the religious or spiritual aspects of its use. These articles were not solely written by Ralph Metzner, but they instead represent the type of work that influenced Metzner during his career. This collection does not contain the personal papers of Ralph Metzner. Instead, it provides insight into the diverse sources that Metzner sampled while conducting his research. Types of papers include: articles, book chapters, photocopies, pamphlets, and clippings. The article files are divided into 15 folders that are based on the following topics:

Ayahuasca and Analogue Pharmacology Ayahuasca Churches Cannabis—Historical/Cultural/Political Cannabis—Science and Therapeutics DMT and Tryptamines—Plant and Synthesized Drug Politics General Pharmacology of Hallucinogens and Psychological Studies

Descriptive Rules Anglo-American Cataloguing Rules, 2nd Edition / Describing Archives: A Content Standard Processing Information Collection is organized topically into fifteen folders.

4/12/2012 6

DETAILED DESCRIPTION OF THE COLLECTION Folder 1: Ayahuasca and Analogue Pharmacology Item 1. Andritzky, Walter. “Sociopsychotherapeutic Functions of Ayahuasca Healing in

Amazonia.” Journal of Psychoactive Drugs 21, no. 1 (January–March 1980). [Photocopy] This article is available electronically in the database PsychINFO.

2. Batchelder, Tim. “Drug Addictions, Hallucinogens and Shamanism: the View from Anthropology.” Townsend Letter for Doctors & Patients: The Examiner of Medical Alternatives 216 (July 2001). [Photocopy; printed note on top states, “From: Jarvin R. Heiman, MD”]

3. Bear, Jaya. “Ayahuasca Shamanism: An Interview with Don Agustín Rivas-Vasquez.” Shaman’s Drum 44, (1997): 43-52.

[Reprint]

4. Callaway, James C. “Ayahuasca, Now and Then.” Eleusis no. 1 (May 1995). [Photocopy]

5. Callaway, J.C. “Pharmahuasca and Contemporary Ethnopharmacology.” Curare 18, no. 2 (1995): 395-398.

[Photocopy]

6. Callaway, James C. “Some Chemistry and Pharmacology of Ayahuasca.” Jahrbuch f. Ethnomedizin (1994).

[Reprint]

7. Callaway, J.C., D.J. McKenna, C.S. Grob, et al. “Pharmacokinetics of Hoasca Alkaloids in Healthy Humans.” Journal of Ethnopharmacology 65 (1999).

[Reprint] This article is available electronically in the database ScienceDirect.

4/12/2012 7

8. Callaway, James C., Lionel P. Raymon, William L. Hearn, et al. “Quantition of N, N- Dimethyltryptamine and Harmala Alkaloids in Human Plasma after Oral Dosing with Ayahuasca.” Journal of Analytical Toxicology 20 (October 1996). [Reprint]

This article is available electronically in the database IngentaConnect Journals.

9. Callaway, James C., Mauno M. Airaksinen, Dennis J. McKenna, et al. “Platelet

Serotonin Uptake Sites Increased in Drinkers of Ayahuasca.” Psychopharmacology 116 (1994).

[Reprint] This article is available electronically in the database PsychINFO.

10. “Chapter 5: Shamanism and Ayllu Regulation.” Sacha Runa. [Chapter out of a larger work; book citation information missing]

[Photocopy; extensive highlighting throughout chapter; brief marginalia, including inscription.]

11. Creedon, Jeremiah. “Ayahuasca.” UTNE Reader (September–October 2001). [Reprint]

12. Grob, Charles S., Dennis J. McKenna, James C. Callaway, et al. “Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil.” The Journal of Nervous and Mental Disease 184, no. 2 (1996). [Reprint]

This article is available electronically in the database PsychINFO.

13. Langdon, E. Jean. “Yagé Among the Siona: Cultural Patterns in Visions.” In Spirits, Shamans, and Stars, edited by David L. Browman and Ronald A. Schwarz, 63- 80. The Hague: Mouton Publishers, 1979.

[Photocopy]

14. Leviton, Richard. “Through the Shaman’s Doorway: Dreaming the Universe with Fred Alan Wolf.” Yoga Journal (July–August 1992).

[Reprint]

15. Luna, Luis Eduardo. “The Ayahuasca Visions of Pablo Amaringo.” Shaman’s Drum (Summer 1990).

[Reprint; pages are out of order]

4/12/2012 8

16. Mabit, Jacques Michel. “L’hallucination par l’ayahuasca chez les guerisseurs de la haute-amazonie peruvienne.” Translated by Kenneth A. Symington. Institute Français d’Etudes Andines (January 1988).

[Reprint]

17. McKenna, Dennis J., G.H.N. Towers, and F. Abbot. “Monoamine Oxidase Inhititors in South American Hallucinogenic Plants: Tryptamine and β-Carboline Constituents of Ayahuasca.” Journal of Ethnopharmacology 10 (1984).

[Photocopy; multiple partial articles contained in one document; numbers written in margins of each page]

18. Novaes da Mota, Clarice, and Jose Flávio Pessoa de Barros. “Jurema: Black- Indigenous Drama and Representations.” Ethnobiology: Implications and Applications, Proceedings of the First International Congress of Ethnobiology, organized by Darrell A. Posey and William Leslie Overal, 171-180. Belém, Brazil, 1990. [Photocopy; notes made in margins of pg. 171. Packet also includes miscellaneous shorter articles on Mount Buffalo and plants in the Legume family (Mimosa subfamily). There are extensive, hand-written notes in the margins of several of these pages. The last page includes a table with three columns: “Species,” “Part of plant extracted (1 kg),” and “Yield DMT”.]

19. Schultes, Richard Evans. “The beta-Carboline Hallucinogens of South America.” Journal of Psychoactive Drugs 14, no. 3 (July–September 1982).

[Photocopy; brief underlining pg. 214-215, check marks in references section]

20. Schultes, Richard Evans. “Indole Alkaloids In Plant Hallucinogens.” Journal of Psychedelic Drugs 8, no. 1 (January–March 1976). [Photocopy; underlining throughout document, brief marginalia on pg. 12]

21. Vepsäläinen, Jouko J., Seppo Auriola, Mikko Tukiainen, et al. “Isolation and Characterization of Yuremamine, a New Phytoindole.” Planta Medica 71 (2005): 1053-1058.

[Reprint]

22. White, Timothy. “It’s Time to End the War Against Entheogens.” Shaman’s Drum no. 64 (2003).

[Photocopy; brief marks and underlines throughout article]

4/12/2012 9

Folder 2: Ayahuasca Churches Item 1. Céu da Montanha 1, no. 1 (September 1988).

[Reprint; in Portuguese]

2. Christensen, Jon. “Worship Pivots on Rain Forest.” The Sunday Oregonian, October 22, 1989, international section.

[Photocopy]

3. Dixon, Susan. “DEA Says Amazon Drug is Illegal: Brew Used on Kaua’i for Spiritual Rituals.” The Entheogen Law Reporter (November 1996).

[Reprint]

4. Gallant, Katheryn. “Tea Party.” News from Brazil (May 1995). [Photocopy]

5. Goldman, Jonathan. “A Brief History of the Santo Daime Religion and the Mission of the Church of the Holy Light of the Queen.” (September 1996). [Reprint]

6. Groisman, Alberto and Ari Bertoldo Sell. “‘Healing Power’: Cultural- Neurophenomenological Therapy of

Santo Daime.” [Paper, publication information unclear] [Reprint]

7. Holland, Gina. “Justices Hear Case on Hallucinogenic Tea.” San Francisco Chronicle, A9.

[Reprint; newspaper clipping]

8. MacRae, Edward. “The Religious Use of Ayahuasca in Contemporary Brazil.” (São Paulo: Escola Paulista de Medicina). [Paper, publication information unclear] [Photocopy] This article is available electronically in the database Factiva.

9. Maier, John. “Drinking the Tea That Liberates.” Time, October 9, 1989. [Photocopy] This article is available electronically in the database ABI/INFORM Complete.

10. Master Irineu and the Santo Daime. Rio de Janeiro, Brazil: Céu da Montanha. [Reprint]

4/12/2012 10

11. O Centro Espirita Beneficiente Uniao Do Vegetal v. John Ashcroft, CIV No. 00-1647 (N.M. Dist. 2002).

[Reprint; Underlining throughout document and notes written in margins. Signature of Chief United States District Judge James A. Parker on final page.]

12. Polari de Alverga, Alex. “Might the Gods be Alkaloids?” International Transpersonal Association’s Annual Conference, Brazil, May 18, 1996.

[Photocopy; some highlighting.]

13. Richman, Gary Dale. “The Santo Daime Doctrine: An Interview with Alex Polari de Alverga.” Shaman’s Drum (Winter 1990–91).

[Photocopy; Marker signature on first page. Underlining throughout document, writing in several margins.]

14. Schmithüsen, Bernhard. “Drogenkonsum in religiösem Kontext aus verfassungsrechtlicher Sicht.” Paper presented March 28, 2007.

[Reprint; in German.]

15. Sharpe, Tom. “Attorney: Group is Free to Drink Psychedelic Tea.” The New Mexican, December 22, 2004, A4.

[Photocopy; handwritten note gives date of the article. Additionally note on back of page is addressed to “Ralph.”]

16. Soares, Luiz Eduardo. “O Santo Daime No Contexto Da Nova Consciência Religiosa.” Sinais Dos Tempos.

[Photocopy; Note addressed to “Ralph” from “Tania Soibelman” on first page. Notes throughout in margins, some underlining. In Portuguese.]

17. “Union of the ‘Vegetal’ *Oasca* is the Religion of Feeling.” Live and Total Consciousness. [Paper, publication information unclear]

[Reprint; note written to Ralph on back of document, dated February 1986.]

18. Weigle, Ewald. “Die wunderbare Heilkraft des Ayahuasca.” In Jahrbuch f. Ethnomedizin (1994). [Reprint; in German.]

Folder 3: Cannabis—Historical/Cultural/Political Item 1. Callaway, J.C. “Cultivation of Hemp as a Nutricious Food.” [sic]

[Photocopy; written note at top attributes paper to a seminar proceeding from the Hankasalmi Hemp Project. It is dated November 17, 1995.]

4/12/2012 11

2. Earleywine, Mitchell. “Marijuana Is Medicine.” San Francisco Chronicle, September 1, 2002, D5. [Photocopy; reverse side has a rebuttal written by John P. Walters.] This article is available electronically in the database ProQuest

NewspaperDirect PressDisplay.

3. Herer, Jack. “This Plant Can Save the World.” In Best of High Times. [Information on editor and publication details not present.] [Photocopy; assorted other articles also included in this packet.]

4. Kaplan, Aryeh. The Living Torah (Brooklyn, NY: Mazmaim Publishing Co., 1981). [Photocopy; written note in bottom margin lists the citation information for the pages. Pages are underlined and highlighted, and some of the pictures are circled. Second page has handwritten note at top.]

5. Marine, Craig. San Francisco Chronicle Magazine, August 12, 2001. [Photocopy]

6. Mikuriya, Tod H. “Cannabis in Western Medicine: An Abbreviated History.” Journal of Psychedelic Drugs 10, no. 3 (July–September 1978). [Reprint]

7. Nadelmann, Ethan. “An End to Marijuana Prohibition.” National Review (July 12, 2004). [Reprint; first page is signed by author. Fourth page has remarks by author at top of the page.] This article is available electronically in the database Academic Search

Premier.

8. Nadelmann, Ethan. “The Future of An Illusion.” National Review (September 27, 2004). [Reprint; packet also contains rebuttal by John P. Walters.] This article is available electronically in the database Academic Search

Premier.

9. Nadelmann, Ethan. “Legalize It: Why It’s Time to Just Say No to Prohibition.” Foreign Policy (September–October 2007). [Reprint]

This article is available electronically in the database Academic Search Premier.

4/12/2012 12

10. Schlosser, Eric. “Reefer Madness.” The Atlantic Monthly, August 1994. [Photocopy; top of first page is addressed, “F.Y.I. Roger.” Article contains brief markings in the margins.] This article is available electronically in the database Academic Search Premier.

11. Touw, Mia. “The Religious and Medicinal Uses of Cannabis in China, India and Tibet.” Journal of Psychoactive Drugs 13, no. 1 (January–March 1981). [Reprint]

12. Zias, Joe, Harley Stark, Jon Sellgman, et al. Letter to the Editor, Nature 363 (May 1993). [Photocopy; portion of first paragraph is highlighted]

This article is available electronically in the database Academic Search Premier.

Folder 4: Cannabis—Science and Therapeutics Item 1. Bailey, Eric. “Canada Approves Cannabis Spray.” Los Angeles Times, April 20, 2005.

http://www.latimes.com/. [Reprint; short written note on first page] This article is available electronically in the database LexisNexis Academic.

2. Billingsley, Janice. “Marijuana-like Ingredient Could Slow Alzheimer’s.” HealthDay News. (accessed March 17, 2005).

[Reprint; article is from an online newspaper that was sent through e-mail to Ralph Metzner from Martin A. Lee.]

3. Callaway, James, Ursula Schwab, Ilkka Harvima, et al. “Efficacy of Dietary Hempseed Oil in Patients with Atopic Dermatitis.” Journal of Dermatological Treatment 16 (2005). [Reprint]

This article is available electronically in the database Academic Search Premier.

4/12/2012 13

4. Fachner, J., E. David, M. Pfotenhauer. “EEG Brainmapping in Altered States of Consciousness Under the Influence of Cannabis While Listening to Selected Pieces of Music—A Single Case Study with Follow-Up.” (Spring Meeting of the Society for the Anthropology of Consciousness, March 27–31, 1996).

[Reprint]

5. Labigalini, Eliseu Jr., Lúcio Ribeiro Rodrigues, Dartiu Xavier da Silveira Filho. “Therapeutical Use of Cannabis by Crack Addicts in Brazil.” [Publishing information not included.] [Photocopy]

6. McPartland, J.M., Patty L. Pruitt. “Side Effects of Pharmaceuticals Not Elicited by Comparable Herbal Medicines: The Case of Tetrahydrocannabinol and Marijuana.” Alternative Therapies 5, no. 4 (July 1999). [Reprint]

7. Myerscough, Rodney, Stuart Taylor. “The Effects of Marijuana on Human Physical Aggression.” Journal of Personality and Social Psychology 49, no. 6 (1985).

[Photocopy; article has highlighting on two pages.] This article is available electronically in the database EBSCOhost PsychArticles.

8. Pate, David W. “Cannabis: The Chemistry of Its Ecology and Evolution.” [Publishing information not Included.]

[Reprint; last page has chart of the Biogenic Scheme of the Cannabinoids. Miscellaneous pen markings throughout.]

Folder 5: DMT and Tryptamines—Plant and Synthesized Item 1. Appleseed, Johnny [pseud.?]. “A Genetic Engineering Primer for the Vision Plants: A

New Vision For Our Time.” [Publishing information not included.] [Photocopy]

2. Benington, F., R.D. Morin, and L.C. Clark, Jr. “5-Methoxy-N, N-Dimethyltryptamine, A Possible Endogenous Psychotoxin.” Alabama Journal of Medical Science 2, no. 4 (1965).

[Photocopy; some passages circled]

4/12/2012 14

3. Gillin, J. Christian, Jared Tinklenberg, David M. Stoff, et al. “5-Methoxy-N, N- Dimethyltryptamine: Behavioral and Toxicological Effects in Animals.” Pathological Psychiatry 11, no. 3 (1976).

[Photocopy]

4. Gillin, J. Christian, Jonathan Kaplan, et al. “The Psychedelic Model of Schizophrenia: The Case of N,N-Dimethyltryptamine.” American Journal of Psychiatry 133, no. 2 (February 1976).

[Photocopy]

6. Holmstedt, B. “Tryptamine Derivatives in Epená An Intoxicating Snuff Used by Some South American Indian Tribes.” Archives Internationales de Pharmacodynamie et de Thérapie 156, no. 2 (1965). [Reprint]

7. Jones, R.S.G. “Tryptamine: A Neuromodulator or Neurotransmitter in Mammalian Brain?” Progress in Neurobiology 19 (1982).

[Photocopy; one marking in references.]

8. Leuner, H. and G. Baer. “Two New Short-Acting Hallucinogens of the Psilocybin Group.” Neuropschopharmacology, no. 4 (1965). [Photocopy; publication information handwritten at top of first page.]

9. Lyttle, Thomas. “Psychedelica mysticae: White Light Drugs and the Search for the Pineal.” Integration, Journal for Mind-Moving Plants and Culture, no. 4 (1993). [Photocopy; brief underlining in article, some circling done in footnotes.]

10. McKenna, Dennis J. and G.H.N. Towers. “Biochemistry and Pharmacology of Tryptamines and beta-Carbolines: a Minireview.” Journal of Psychoactive Drugs 16, no. 4 (October–December 1984).

[Reprint]

11. McKenna, Dennis J., G.H.N. Towers, and F. Abbott. “Monoamine Oxidase Inhibitors in South American Hallucinogenic Plants: Tryptamine and β-Carboline Constituents of Ayahuasca.” Journal of Ethnopharmacology 10 (1984).

[Photocopy]

12. Richards, William A. “Mystical and Archetypal Experiences of Terminal Patients in DPT-Assisted Psychotherapy.” Journal of Religion and Health 17, no. 2 (1978).

[Reprint] This article is available electronically in the database JSTOR .

4/12/2012 15

13. Richards, William A., John C. Rhead, Francesco B. DiLeo, et al. “The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients.” Journal of Psychedelic Drugs 9, no. 1 (January–March 1977).

[Photocopy] This article is available electronically in the database JSTOR.

14. Richards, William A., John C. Rhead, Stanislav Grof, et al. “DPT as an Adjunct in Brief Psychotherapy with Cancer Patients.” Omega 10, no. 1 (1979).

[Reprint]

15. Shulgin, Alexander T. and Michael F. Carter. “N,N-Diisopropyltryptamine (DIPT) and 5-Methoxy-N,N-Diisopropyltryptamine (5-MEO-DIPT). Two Orally Active Tryptamine Analogs with CNS Activity.” Communications in Psychopharmacology 4 (1980).

[Reprint; brief marginalia in “References” section]

16. Smith, Terence A. “Tryptamine and Related Compounds in Plants.” Phytochemistry 16, no.2 (1977). [Photocopy] This article is available electronically in the database Elsevier SD Backfile

Complete.

17. Strassman, Rick J. “Human Hallucinogenic Drug Research in the United States: A Present-day Case History and Review of the Process.” Journal of Psychoactive Drugs 23, no. 1 (January–March 1991).

[Reprint]

18. Torres, Constantino Manuel. “Snuff Trails of Atacama: Psychedelics and Iconography in Prehispanic San Pedro de Atacama.” Integration, Journal for Mind-Moving Plants and Culture, no. 4 (1993).

[Reprint]

19. Torres, Constantino Manuel, David B. Repke, Kelvin Chan, et al. “Snuff Powders from Pre-Hispanic San Pedro de Atacama: Chemical and Contextual Analysis.” Current Anthropology 32, no. 5 (December 1991).

[Photocopy] This article is available electronically in the database\JSTOR Arts and Sciences.

20. Wassén, S. Henry and Bo Holmstedt. “The Use of Paricá, an Ethnological and Pharmacological Review.” Ethnos 1 (1963). [Photocopy; ink dots on pages throughout second half of document.]

4/12/2012 16

Folder 6: Drug Politics Item 1. Nadelmann, Ethan A. “America’s Drug Problem.” The American Academy of Arts and

Sciences Bulletin 45, no. 3 (December 1991). [Photocopy] This article is available electronically in the database JSTOR.

2. Nadelmann, Ethan A. “Beyond Drug Prohibition: Evaluating the Alternatives.” In Searching for Alternatives: Drug-Control Policy in the United States, edited by Melvyn B. Krauss and Edward P. Lazear, 241-250. Hoover Institution Press, 1991.

[Photocopy]

3. Nadelmann, Ethan A. “The Case for Legalization.” The Public Interest, no. 92 (Summer 1988). [Photocopy] This article is available electronically in the database ProQuest Research

Library.

4. Nadelmann, Ethan A. “Commonsense Drug Policy.” Foreign Affairs, January– February 1998. [Photocopy] This article is available electronically in the database Wilson OmniFile FT

Mega.

5. Nadelmann, Ethan A. “Drug Prohibition in the United States: Costs, Consequences, and Alternatives.” Science 245 (September 1989).

[Photocopy] This article is available electronically in the database ProQuest Research Library.

6. Nadelmann, Ethan A. “A Rational Approach to Drug Legalization.” American Journal of Ethics and Medicine (Spring 1991).

[Photocopy]

4/12/2012 17

7. Nadelmann, Ethan A. “Thinking Seriously About Alternatives to Drug Prohibition.” Daedalus 121, no. 3 (Summer 1992).

[Photocopy] This article is available electronically in the database ProQuest Research Library.

8. Nadelmann, Ethan A. “U.S. Drug Policy: A Bad Report.” Foreign Policy, no. 70 (Spring 1988). [Photocopy]

This article is available electronically in the database ProQuest Research Library.

9. Nadelmann, Ethan A., Mark A.R. Kleiman, Felton J. Earls. “Should Some Illegal Drugs Be Legalized?” Issues in Science and Technology 6, no. 4 (Summer 1990).

[Photocopy] This article is available electronically in the database MasterFILE Premier.

Folder 7: General Pharmacology of Hallucinogens and Psychological Studies Item 1. Borsutzky, M., T. Passie, W. Paetzold, et al. “Hawaiianische Holzrose: (Psycho-)

Pharmakologische Wirkungen der Samen der Argyreia nervosa.” Nervenartzt 73 (2002).

[Photocopy; In German] This article is available electronically in the database Springer Complete Collection.

2. Bunce, Richard. “Social and Political Sources of Drug Effects: The Case of Bad Trips on Psychedelics.” Journal of Drug Issues (Spring 1979).

[Reprint; ink underlining throughout]

3. Grob, Charles S. “Psychiatric Research with Hallucinogens: What Have We Learned?” Yearbook for Ethnomedicine and the Study of Consciousness 3 (1994).

[Photocopy; Offprint from an earlier book. Offprint is dated from 1996.]

4/12/2012 18

4. Holland, Doris. “Flashback-Phänomene als Nachwirkung von Halluzinogeneinnahme: Eine kritische Untersuchung zu geschichtlichen, phänomenologischen, klinischen und ätiologischen Aspekten.” Dissertation, Medizinischen Hochschule Hannover, 2001.

[Photocopy; front page has brief note in margin; in German.]

5. Jacobs, Barry L. “Postsynaptic Serotonergic Action of Hallucinogens.” In Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives, edited by Barry L. Jacobs, 183-202. New York: Raven Press, 1984.

[Photocopy]

6. Krippner, Stanley. “Illicit Drug Usage: Hazards for Learning Disability Students.” Orthomolecular Psychiatry 1, no. 1 (1972).

[Reprint]

7. Krippner, Stanley. “The Psychedelic State, the Hypnotic Trance, and the Creative Act.” [Document is part of a larger work, citation information is missing.] [Photocopy]

8. Krippner, Stanley. “Research in Creativity and Psychedelic Drugs.” The International Journal of Clinical and Experimental Hypnosis 25, no. 4 (1977). [Reprint]

9. Meltzer, Herbert Y., Miljana Simonovic, Victor S. Fang, et al. “Neuroendocrine Effects of Psychotomimetic Drugs.” McLean Hospital Journal 6, no. 2 (1981). [Photocopy; passages highlighted throughout]

10. Metzner, Ralph. “On the Evolutionary Significance of Psychedelics.” Main Currents of Modern Thought 25, no. 1 (1968).

[Photocopy]

11. Passie, Torsten. “Hanscarl Leuner: Pioneer of Hallucinogen Research and Psycholytic Therapy.” Maps 7, no. 1 (Winter 1996–1997). [Photocopy]

12. Passie, Torsten. “Imaginationsteigerung und halluzinogene Substanzen: Die Entwicklungsbeziehungen von Katathymem Bilderleben (KB) und psycholytischer Therapie.” [Paper, publication information is unclear missing.] [Photocopy; in German.]

13. Passie, Torsten. “Psychische Wirkungen von Halluzinogenen: Objektive und subjective Perspektiven.” [Paper, publication information is missing.] [Photocopy; in German.]

4/12/2012 19

14. Passie, Torsten. “Was sind Entaktogene? Zur Phänomenologie ihrer Psychopharmakologie.” [Paper, publication information is missing.] [Photocopy; in German.]

15. Rhead, John C. “The Use of Psychedelic Drugs in the Treatment of Severely Disturbed Children: A Review.” Journal of Psychedelic Drugs 9, no. 2 (April– June 1977). [Photocopy; brief underlining of passages]

16. Shulgin, Alexander T. “Profiles of Psychedelic Drugs.” Journal of Psychedelic Drugs 9, no. 2 (April–June 1977). [Photocopy]

17. Siegel, Ronald K. “Hallucinations.” Scientific American, October 1977. [Reprint]

18. Siegel, Ronald K. “Hallucinations.” Scientific American, October 1977. [Photocopy; brief marginalia.]

19. Siegel, Ronald K. “Religious Behavior in Animals and Man: Drug-Induced Effects.” Journal of Drug Issues 7, no. 3 (Summer 1977).

[Photocopy]

20. Strassman, Rick J. “Adverse Reactions to Psychedelic Drugs.” The Journal of Nervous and Mental Disease 172, no. 10 (October 1984).

[Photocopy; signature on top of first page. Brief circling within document.]

21. Strassman, Rick J. “Hallucinogenic Drugs in Psychiatric Research and Treatment: Perspectives and Prospects.” The Journal of Nervous and Mental Disease 183, no. 3 (1995). [Photocopy]

22. “The Subjective After-Effects of Psychedelic Experiences: A Summary of Four Recent Questionnaire Studies.” The Psychedelic Review. [Volume information is missing.] [Photocopy]

Folder 8: Hallucinogenic Mushrooms: Psilocybe/Amanita Item 1. De Borhegyi, Carl. “Hidden in Plain Sight: Internet Study Now Links Venus Cult and

Religious Practices of Ancient Mexico, Guatemala, and South America to Easter Island.” Presentation, Southdale-Hennepin Area Library, Edina, MN, June 12, 2008. [Reprint; document is an advertisement and description of the forthcoming Presentation]

4/12/2012 20

2. Buck, Robert W. “Mushroom Toxins—A Brief Review of the Literature.” New England Journal of Medicine 265 (October 1961). [Reprint; brief underlining. Document contains insert from Mycologia 53 (1961)]

This article is available electronically in the database JSTOR Life Sciences.

3. Chilton, W. Scott, Jeremy Bigwood, and Robert E. Jensen. “Psilocin, Bufotenine and

Serotonin: Historical and Biosynthetic Observations.” Journal of Psychedelic Drugs 11, no. 1–2 (January–June 1979). [Reprint]

4. Crowley, Mike. “The God Who Drank Urine.” [Paper, possibly unpublished.] [Reprint]

5. Gartz, Jochen. “Further Investigations on Psychoactive Mushrooms of the Genera Psilocybe, Gymnopilus and Conocybe.” Rovereto: Musei civici di Rovereto, Sezione archeologia-storia-scienze naturali 7 (1991).

[Photocopy]

6. Graves, Robert. “The Sacred-Mushroom Trance.” Story, May–June 1963. [Photocopy]

7. Hoffman, Mark. “Mushroom Myth and Imagery in Hawai’i: Evidence for an Indigenous Cult.” The Entheogen Review 11, no. 2 (Summer 2002). [Photocopy]

8. Kaplan, Reid W. “The Sacred Mushroom in Scandinavia.” Man 10 (1975). [Photocopy; citation handwritten at top of first page]

This article is available electronically in the database JSTOR Arts and Sciences.

9. Krippner, Stanley and Michael Winkelman. “Maria Sabina: Wise Lady of the

Mushrooms.” [Citation information not discernible.] [Reprint]

10. Laurie, Erynn Rowan and Timothy White. “Speckled Snake, Brother of Birch: Amanita Muscaria Motifs in Celtic Legends.” Shaman’s Drum, no. 44 (1997).

[Reprint; extensive underlining and circling throughout]

11. Passie, Torsten. “Psilocybin in der modernen Psychotherapie.” Curare 18, no. 1 (1995). [Reprint]

4/12/2012 21

12. Passie, Torsten, Juergen Seifert, Udo Schneider, Hinderk M. Emrich. “The Pharmacology of Psilocybin.” Addiction Biology 7 (2002).

[Reprint; first page is inscribed to Ralph Metzner from Torsten Passie.] This article is available electronically in the database Academic Search Premier.

13. Samorini, Giorgio. “Umbrella-Stones Or Mushroom-Stones?” Integration, Journal for Mind-Moving Plants and Culture, no. 6 (1995).

[Reprint; inside of front cover bears inscription from author to Ralph.]

14. Stijve, Tjakko and Beowulf Glutzenbaum. “Experiences with a Rare Psychoactive Mushroom, Inocybe Haemacta Berk. Et Br.” Eleusis 2 (1999).

[Photocopy; document written in both Italian and English]

Folder 9: Hallucinogenic Toad Venoms Item 1. Davis, Wade and Andrew T. Weil. “Identity of a New World Psychoactive Toad.”

Ancient Mesoamerica 3 (1992). [Photocopy; some circling in references section]

2. Deulofeu, Venancio, and Edmundo Rúveda. “The Basic Constituents of Toad Venoms.” In Venomous Vertebrates, edited by Wolfgang Bücherl and Eleanor Buckley, 475–495. New York: Academic Press, 1971.

[Photocopy; handwritten notes on first page]

3. Erspamer, V., T. Vitali, M. Roseghini, et al. “5-Methoxy- and 5-Hydroxy- Indolealkylamines in the Skin of Bufo alvarius.” Experientia 21, no.9.

[Photocopy]

4. Kennedy, Alison Bailey. “Ecce Bufo: The Toad in Nature and in Olmec Iconography.” Current Anthropology 23, no. 3 (June 1982). [Reprint]

This article is available electronically in the database JSTOR.

5. Lyttle, Thomas, David Goldstein, and Jochen Gartz. “Bufo Toads and Bufotenine: Fact and Fiction Surrounding an Alleged Psychedelic.” Journal of Psychoactive Drugs 28, no. 3 (September 1996). [Photocopy]

4/12/2012 22

6. “Ritual Feasts: The Cuch Ceremony.” In The Traditional Role of Women and Animals in Lowland Maya Economy. [Publishing information and author not discernible.]

[Photocopy; brief highlighting]

Folder 10: Ketamine Item 1. Khorramzadeh, E., and A.O. Lotfy. “The Use of Ketamine in Psychiatry.”

Psychosomatics 14 (November–December 1973). [Photocopy]

2. Krystal, John H., Laurence P. Karper, John P. Seibyl, et al. “Subanesthetic Effects of the Noncompetitive NMDA Antagonist , Ketamine, in Humans.” Archives of General Psychiatry 51 (March 1994). [Photocopy]

3. Passie, Torsten, Matthias Karst, Mathias Borsutzky, et al. “Effects of Different Subanaesthetic Doses of (S)-ketamine on Psychopathology and Binocular Depth Inversion in Man.” Journal of Psychopharmacology 17, no.1 (2003).

[Reprint]

4. Perry, Edward B., Jr., Joyce A. Cramer, Hyun-Sang Cho, et al. “Psychiatric Safety of Ketamine in Psychopharmacology Research.” Psychopharmacology 192 (2007).

[Photocopy] This article is available electronically in the database Academic Search Premier.

5. Rogo, D. Scott. “Ketamine and the Near-Death Experience.” Anabiosis—The Journal for Near-Death Studies 4, no. 1 (Spring 1984).

[Reprint]

6. Siegel, Ronald K. “Phencyclidine and Ketamine Intoxication: A Study of Four Populations of Recreational Users.” NIDA Research Monograph 21 (August 1978).

[Photocopy; brief markings]

4/12/2012 23

Folder 11: LSD Item 1. Bleibtreu, John N. “LSD and the Third Eye.” The Atlantic Monthly. [Issue information

not discernible.] [Photocopy]

This article is available electronically in the database Academic Search Premier.

2. Brown, Barbara B. “LSD and Brain Wave Responses to Color.” 1966.

[Reprint; title of publication indicated on first page. Underlining throughout document.]

3. Fort, Joel and Ralph Metzner. “LSD, Chromosomes and Sensationalism.” Psychedelic Review 10. [Reprint; revised edition]

4. Hawaii Medical Journal 41, no. 12 (December 1982). [Photocopy]

5. Horowitz, Michael. “Interview: Albert Hofmann.” High Times. [Publishing information not discernible.] [Reprint]

6. Isernhagen, H. “Acid Against Established Realities: A Transcultural and Transdisciplinary View of LSD and Related Hallucinogens.” In Fifty Years of LSD: Current Status and Perspectives of Hallucinogens: A Symposium of the Swiss Academy of Medical Sciences, Lugano-Agno (Switzerland), October 21 and 22, 1993, edited by A. Pletscher and D. Ladewig, 121-131. New York: Parthenon Publishing Group, 1994. [Photocopy]

7. Ling, Thomas M. and John Buckman. “The Treatment of Frigidity with LSD and Ritalin.” The Psychedelic Review 1, no. 4 (1964).

[Reprint]

8. McGlothlin, William H., Sidney Cohen, and Marcella S. McGlothlin. “Short-Term Effects of LSD on Anxiety, Attitudes and Performance.” The Journal of Nervous and Mental Disease 139, no. 3 (September 1964).

[Reprint; outer front cover has writing]

4/12/2012 24

9. McGlothlin, William, Sidney Cohen, and Marcella S. McGlothlin. “Long Lasting Effects of LSD on Normals.” Archives of General Psychiatry 17 (November 1967).

[Reprint; “Metzner” written on front page, brief marginalia]

10. McWilliams, Spencer A. and Renée J. Tuttle. “Long-Term Psychological Effects of LSD.” Psychological Bulletin 79, no. 6 (1973).

[Reprint]

11. Metzner, Ralph. “Reflections on LSD—Ten Years Later.” Journal of Psychedelic Drugs 10, no. 2 (April–June 1978). [Reprint]

12. Novak, Steven J. “LSD before Leary: Sidney Cohen’s Critique of 1950s Psychedelic Drug Research.” Isis 88 (1997). [Photocopy]

This article is available electronically in the database EBSCOhost America History and Life.

13. Silling, Marc S. “LSD Flashbacks: An Overview of the Literature for Counselors.”

American Mental Health Counselors Association Journal (January 1980). [Photocopy; passages throughout article are underlined]

14. “Simple Extraction Methods of LA-111 from Argyreia and Ipomoea Species.” Version 1 (1996). [Reprint]

15. Snyder, Solomon H. and Martin Reivich. “Regional Localization of Lysergic Acid Diethylamide in Monkey Brain.” Nature 209, no. 5028 (March 1966).

[Reprint] Folder 12: Ecstasy/MDMA and Related Phenethylamines  Item 1. Abramson, David. “The New Drug Underground.” New Age, October 1985.

[Reprint]

2. Barnes, Edward, Susan Peters, and Janet Zich. “The Trouble with Ecstasy.” [Publication information not discernible.] [Reprint]

3. Bartlett, Thomas. “Ecstasy Agonistes.” The Chronicle of Higher Education, February 27, 2004.

4/12/2012 25

[Photocopy]

This article is available electronically in the database Academic Search Premier.

4. Braun, Ulrich, Alexander T. Shulgin, and Gisela Braun. “Centrally Active N-

Substituted Analogs of 3,4-Methylenedioxyphenylisopropylamine (3, 4- Methylenedioxyamphetamine).” Journal of Pharmaceutical Sciences 69, no. 2 (February 1980).

[Reprint; brief note on first page] This article is available electronically in the database Wiley Online Library Backfile Complete.

5. Braun, Ulrich, Gisela Braun, Peyton Jacob III, et al. “Mescaline Analogs: Substitutions at the 4-Position.” ‘QUASAR’ Research Monograph 22, edited by G. Barnett, M. Trsic, and R. Willette. National Institute on Drug Abuse, 1978.

[Photocopy]

6. Buchanan, James. “Ecstasy in the Emergency Department.” Update 7, no. 4 (July– August 1985). [Photocopy]

7. Check, Erika. “The Ups and Downs of Ecstasy.” Nature 429 (May 2004). [Photocopy]

This article is available electronically in the database Gale Cengage Health Reference Center Academic.

8. Climko, Robert P., Herbert Roehrich, Donald R. Sweeney, et al. “Ecstacy: A Review

of MDMA and MDA.” [sic] International Journal of Psychiatry in Medicine 16, no. 4 (1986–87). [Photocopy]

9. Dawn, Randee. “Reality Check.” Soap Opera Digest 26, no. 27 (July 2001). [Photocopy]

10. “Ecstasy: The Truth about MDMA.” High Times (November 1985). [Reprint]

11. Greer, George. MDMA: A New Psychotropic Compound and Its Effects in Humans. Santa Fe, NM: George Greer, 1983. [Reprint]

4/12/2012 26

12. Greer, George and Requa Tolbert. “Subjective Reports of the Effects of MDMA in a Clinical Setting.” Journal of Psychoactive Drugs 18, no. 4 (October– December 1986).

[Reprint; last page includes a table of subjects’ reports]  

13.

Grob, Charles S. “The Politics of Ecstasy.” Journal of Psychoactive Drugs 34, no. 2 (April–June 2002). [Reprint]

14. Naranjo, C., Alexander T. Shulgin, and T. Sargent. “Evaluation of 3,4- Methylenedioxyamphetamine (MDA) as an Adjunct to Psychotherapy.” Medical Pharmacology (1967). [Reprint]

15. Naranjo, C., Alexander T. Shulgin, and T. Sargent. “Evaluation of 3,4- Methylenedioxyamphetamine (MDA) as an Adjunct to Psychotherapy.” Medical Pharmacology (1967). [Reprint; duplicate copy]

16. Nasmyth, Peter. “The Agony and the Ecstasy: Flaws in the New Designer Drugs.” The Face. [Publication information not discernible.]

[Photocopy]

17. Passie, Torsten, Uwe Hartmann, Udo Schneider, et al. “Was sind Entaktogene? Pharmakologische und psychopharmakologische Aspekte einer Substanzgruppe.” Suchtmed 7, no. 4 (2005).

[Photocopy; abstract in German and English, article in German.]

18. “Pushing Bad Drug Policy.” Editorial. San Francisco Chronicle, September 10, 2001. [Photocopy; page also includes editorial from The New York Times.]

This article is available electronically in the database Factiva.

19. Ricaurte, G., G. Bryan, L. Strauss, et al. “Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals.” Science 229 (September 1985).

[Reprint; some passages are circled] This article is available electronically in the database Gale Biography in Context.

20. Rosenbaum, Marsha. “Ecstasy, Science and Politics.” San Francisco Chronicle, August 14, 2001. [Photocopy]

This article is available electronically in the database Factiva.

4/12/2012 27

21. Rosenbaum, Marsha. “Telling Our Children What We Know About Ecstasy.” The San Diego Union-Tribune, August 9, 2001.

[Photocopy] This article is available electronically in the database Gale Cengage GreenR.

22. Shulgin, Alexander T. “Chemistry of Phenethylamines Related to Mescaline.” Journal of Psychedelic Drugs 11, no. 1–2 (January–June 1979).

[Reprint; first page has handwritten inscription]

23. Shulgin, Alexander T. “Composition of the Myristicin Fraction from Oil of Nutmeg.” Nature 197, no. 4865 (January 1963).

[Reprint]

24. Shulgin, Alexander T. “Possible Implication of Myristicin as a Psychotropic Substance.” Nature 210, no. 5034 (April 1966).

[Reprint]

25. Shulgin, Alexander T. “Profiles of Psychedelic Drugs.” Journal of Psychedelic Drugs 8, no. 4 (October–December 1976).

[Photocopy]

26. Shulgin, Alexander T. “Psychotomimetic Agents Related to Mescaline.” Separatum Experientia 19, no. 127 (1963). [Reprint]

27. Shulgin, Alexander T. “Psychotomimetic Amphetamines: Methoxy 3, 4- Dialkoxyamphetamines.” Separatum Experientia 20, no. 366 (1964). [Reprint; handwritten blurb on conversion of units, brief underlining]

28. Shulgin, Alexander T. “The Six Trimethoxyphenylisopropylamines (Trimethoxyamphetamines).” Journal of Medicinal Chemistry 9, no. 445 (1966). [Reprint]

29. Shulgin, Alexander T. “3-Methoxy-4,5-methylenedioxy Amphetamine, a New Psychotomimetic Agent.” Nature 201, no. 4924 (March 1964).

[Reprint]

30. Shulgin, Alexander T. and David E. Nichols. “Characterization of Three New Psychotomimetics.” In The Psychopharmacology of Hallucinogens, edited by Richard C. Stillman and Robert E. Willette. New York: Pergamon Press, 1978.

[Photocopy; citation information handwritten on first page]

4/12/2012 28

31. Shulgin, Alexander T. and H.O. Kerlinger. “Isolation of Methoxyeugenal and Trans- Isoelemicin from Oil of Nutmeg.” Sonderdruck aus die Naturwissenschaften 15 (1964).

[Reprint]

32. Shulgin, Alexander T., Sterling Bunnell, and Thornton Sargent III. “The Psychotomimetic Properties of 3, 4, 5-Trimethoxyamphetamine.” Nature 189, no. 4769 (March 1961). [Reprint]

33. Shulgin, Alexander T., Sterling Bunnell, and Thornton Sargent III. “The Psychotomimetic Properties of 3, 4, 5-Trimethoxyamphetamine.” Nature 189, no. 4769 (March 1961).

[Reprint; duplicate]

34. Shulgin, Alexander T. and Thornton Sargent. “Psychotropic Phenylisopropylames Derived from Apiole and Dillapiole.” Nature 215 (September 1967).

[Photocopy; underlining of passages on second page]

35. Shulgin, Alexander T., Thornton Sargent, and Claudio Naranjo. “The Chemistry and Psychopharmacology of Nutmeg and of Several Related Phenylisopropylamines.” [Reprint]

36. Shulgin, Alexander T., Thornton Sargent, and Claudio Naranjo. “Role of 3, 4- Dimethoxyphenethylamine in Schizophrenia.” Nature 212, no. 5070 (December 1966).

[Reprint]

37. Shulgin, Alexander T., Thornton Sargent, and Claudio Naranjo. “Structure-Activity Relationships of One-Ring Psychotomimetics.” Nature 221 (February 1969). [Photocopy]

38. Shulgin, Alexander T., Thornton Sargent, and Claudio Naranjo. “4-Bromo-2, 5- Dimethoxyphenylisopropylamine, a New Centrally Active Amphetamine Analog.” Pharmacology 5 (1971). [Photocopy]

39. Snyder, Solomon H. and Louis Faillace. “2, 5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug.” Science 158 (November 1967).

[Reprint] This article is available electronically in the database High Wire Press.

4/12/2012 29

40. Truitt, Edward B., Jr. Panel discussion with Claudio Naranjo, Thornton Sargent, Alexander T. Shulgin, and Andrer T. Weil. [Further information not discernible.] [Reprint]

41. Uhlig, Robert. “Ecstasy Fears Based on ‘Flawed Tests’.” Telegraph, April 18, 2002. http://www.telegraph.co.uk.com (accessed April 21, 2002). [Reprint]

42. Weil, Andrew T. “Letters from Andrew Weil: The Love Drug.” Journal of Psychedelic Drugs 8, no. 4 (October–December 1976).

[Photocopy]

43. Zimmerman, Rachel. “FDA Permits Test of Ecstasy as Aid in Stress Disorder.” Wall Street Journal, November 6, 2001.

[Photocopy; edge of page has information about who printed it] Folder 13: Miscellaneous Plant Hallucinogens Item 1. Damuzi, Reverend. “Entheobotany II.” Cannabis Culture Magazine, January 06,

2002. http://www.cannabisculture.com/articles/2154.html. [Photocopy]

2. Davis, Wade E. and James A. Yost. “The Ethnobotany of the Waorani of Eastern Ecuador.” Botanical Museum Leaflets 3 (Summer 1983).

[Photocopy; stamp from Smithsonian libraries on first page; pages are numbered by hand]

3. Dobkin de Rios, Marlene. “Socio-Economic Characteristics of an Amazon Urban Healer’s Clientele.” Social Science and Medicine 15B (1981).

[Photocopy; source includes appendix with questionnaire]

4. Dobkin de Rios, Marlene and Mercedes Cardenas. “Plant Hallucinogens, Shaminism and Nazca Ceramics.” Journal of Ethnopharmacology 2 (1980).

[Reprint; brief note on front cover; brief marginalia in reference section]

5. Farnsworth, Norman R. “Hallucinogenic Plants.” Science 162 (December 1968). [Photocopy]

This article is available electronically in the database JSTOR Life Sciences Collection.

4/12/2012 30

6. Granier-Doyeux, Marcel. “Native Hallucinogenic Drugs Piptadenias.” Bulletin on Narcotics 17, no. 2 (April–June 1965). [Reprint]

7. Groark, Kevin P. “Ritual and Therapeutic Use of ‘Hallucinogenic’ Harvester Ants (Pogonomyrmex) in Native South-Central California.” Journal of Ethnobiology 16, no. 1 (Summer 1996).

[Photocopy]

8. Li, Hui-Lin. “Hallucinogenic Plants in Chinese Herbals.” Journal of Psychedelic Drugs 10, no. 1 (January–March 1978).

[Photocopy]

9. MacDougall, Thomas. “Ipomea Tricolor A Hallucinogenic Plant of the Zapotecs.” Boletin del Centro de Investigaciones Antropologicas de Mexico, no. 6 (March 1960). [Photocopy; brief marginalia on first page]    

10. MacDougall, Thomas. “Ipomea Tricolor A Hallucinogenic Plant of the Zapotecs.” Boletin del Centro de Investigaciones Antropologicas de Mexico, no. 6 (March 1960). [Photocopy; brief marginalia on first page; duplicate copy]

11. Marles, Robin J., David A. Neill, and Norman R. Farnsworth. “A Contribution to the Ethnopharmacology of the Lowlands Quichua People of Amazonian Ecuador.” Revista de la Academia Colombiana de Ciencias Exactas, Fisicas y Naturales 16, no. 63 (1988).

[Photocopy; brief highlight of author’s name on first page]

12. Mayagoitia, Lilian, José-Luis Díaz, and Carlos M. Contreras. “Psychopharmacologic Analysis of an Alleged Oneirogenic Plant: Calea Zacatechichi.” Journal of Ethnopharmacology 18 (1986).

[Photocopy; brief marginalia]

13. Most, Albert. Peganum harmala: The Hallucinogenic Herb of the American Southwest. Denton, TX: Venom Press, 1985.

[Reprint]

14. Most, Stephen. “Stoned White Magic in Peru.” (January 1972). [Publication information not discernible.] [Photocopy]

15. Schultes, Richard Evans. “Botanical Sources of the New World Narcotics.” Psychedelic Review 1, no. 2 (Fall 1963).

[Reprint]

4/12/2012 31

16. Schultes, Richard Evans. “De Plantis Toxicariis e Mundo Novo Tropicale Commentationes XV: Desfontainia: A New Andean Hallucinogen.” Botanical Museum Leaflets 25, no. 3 (1977).

[Photocopy]

17. Schultes, Richard Evans. “Ein halbes Jahrhundert Ethnobotanik amerikanischer Halluzinogene.” Planta Medica: Zeitschrift für Arzneipflanzenforschung 2 (May 1965).

[Reprint; in German]

18. Schultes, Richard Evans. “Hallucinogens of Plant Origin.” Science 163 (January 1969). [Reprint]

This article is available electronically in the database JSTOR Life Sciences Collection.

19. Wurdack, J.J. “Indian Narcotics in Southern Venezuela.” The Garden Journal (July–

August 1958). [Photocopy; document has a stamp of date in upper corner of first page]

20. Zardini, Elisa M. “The Identification of an Argentinian [sic] Narcotic.” Botanical Museum Leaflets 25, no. 3 (1977). [Photocopy]

Folder 14: Nightshades/datura and Miscellaneous Other Hallucinogens Item 1. Bert, Maryse, René Marcy, Marie-Anne Quermonne, et al. “Non-Amphetaminic

Central Stimulation by Alkaloids from the Ibogane and Vobasine Series.” Planta Medica (1988).

[Photocopy] This article is available electronically in the database Thieme eJournals.

2. Callaway, J.C. “A Proposed Mechanism for the Visions of Dream Sleep.” Medical Hypotheses 26 (1988). [Photocopy]

This article is available electronically in the database Science Direct.

4/12/2012 32

3. Grob, Charles and Marlene Dobkin de Rios. “Adolescent Drug Use in Cross-Cultural Perspective.” The Journal of Drug Issues 22, no. 1 (1992).

[Reprint] This article is available electronically in Academic Search Premier.

4. Hofmann, Albert. “Die Wirkstoffe der mexikanischen Zauberdroge ‘Ololiuqui’.” Planta Medica: Zeitschrift für Arzneipflanzenforschung 4 (December 1961).

[Reprint; inscribed and signed by Albert Hofmann; article in German]

5. Johnson, Cecil E. “Mystical Force of the Nightshade.” International Journal of Neuropsychiatry (May–June 1968).

[Photocopy]

6. Metzner, Ralph. “On the Evolutionary Significance of Psychedelics.” Main Currents of Modern Thought 25, 1 (1968).

[Reprint; editing marks and sections crossed out throughout article]

7. Metzner, Ralph. “Subjective Effects of Anti-Cholinergic Hallucinogens.” Journal of Psychedelic Drugs 9, no. 4 (October–December 1977).

[Reprint]

8. Rätsch, Christian and Heinz Jürgen Probst. “Xtohk’Uh: zur Ethnobotanik der Datura spp. bei den Maya in Yucatan.” (1985). [Photocopy; article published in a journal in 1985 under a slightly different title. This appears to be an unpublished version. In German.]

9. Russo, Ethan B. “Headache Treatments by Native Peoples of the Ecuadorian Amazon: A Preliminary Cross-Disciplinary Assessment.” Journal of Ethnopharmacology 36 (1992). [Reprint]

10. Weil, Andrew T. “Observations on Consciousness Alteration: Some Notes on Datura.” Journal of Psychedelic Drugs 9, no. 2 (April–June 1977).

[Photocopy] Folder 15: Peyote and San Pedro Cactus Item 1. Agurell, Stig, Jan G. Bruhn, Jan Lundström, et al. “Cactaccae Alkaloids. X. Alkaloids

of Trichocereus Species and Some Other Cacti.” Lloydia 34, no. 2 (June 1971).

[Photocopy; full article, brief marginalia]

4/12/2012 33

2. Agurell, Stig, Jan G. Bruhn, Jan Lundström, et al. “Cactaccae Alkaloids. X. Alkaloids of Trichocereus Species and Some Other Cacti.” Lloydia 34, no. 2 (June 1971).

[Photocopy; partial article]

3. Blosser, Bret. “The Return of the Peyoteros.” Whole Earth Review (Summer 1992). [Photocopy]

4. Crosby, D.M. and J.L. McLaughlin. “Cactus Alkaloids. XIX. Crystallization of Mescaline HCl and 3-Methoxytyramine HCl from Trichocereus pachanoi.” Lloydia 36, no. 4 (December 1973). [Photocopy; brief marginalia, underlining throughout document]

5. Davis, E. Wade. “Sacred Plants of the San Pedro Cult.” Botanical Museum Leaflets 29, no. 4 (Fall 1983). [Photocopy; pages are numbered by hand]

6. Dobkin, Marlene. “Trichocereus pachanoi—A Mescaline Cactus Used in Folk Healing in Peru.” (1967) [Journal title, volume information missing.] [Photocopy]

This article is available electronically in the database JSTOR.

7. Employment Division v. Smith, 494 US 872. In U.S. Supreme Court Reports [Information on publishing details, editor not discernible.]

[Photocopy; brief marginalia]

8. Fikes, Jay Courtney. “Native American Church: Concerning the History, Legal Status and the Need for Federal Legislation.” [Publication information not discernible.] [Photocopy; document may be unprinted]

9. Gorman, Peter. “Quanah Parker: The Man Who Brought Peyote to North America.” High Times [publishing information, editors, and date are not discernible.] [Reprint; article is made up of pages from the High Times magazine and the Best of High Times Book.]

10. Gottlieb, Adam. Peyote and Other Psychoactive Cacti. Kistone Press, 1977. [Photocopy; passages highlighted throughout; brief marginalia]

11. Joralemon, Donald. Symbolic Space and Ritual Time in a Peruvian Healing Ceremony. San Diego: San Diego Museum of Man, 1984. [Photocopy; pages numbered by hand]

12. Lake, Robert. “The Plant People.” Herbs 1 (November 1988). [Photocopy; citation information is indicated in handwritten note. First page

4/12/2012 34

has signature (photocopied) of Robert Lake.]

13. Native American Rights Fund: Legal Review 20, no. 1 (Winter–Spring 1995). [Reprint; journal contains various articles that pertain to Peyote use]

14. Ostolaza, Carlos. “Trichocereus Pachanoi Br. and R.” Cactus and Succulent Journal 56 (1984). [Photocopy]

15. Patchen, Jerry D. “The Jurisprudence of Peyote (Lophophora williamsii) in North America.” [Publication information uncertain.]

[Photocopy; document may be unpublished]

16. The Peyote Awareness Journal 1, no. 1 (July–August 1996). [Reprint]  

17. “Peyote Way Church of God, Inc. v. Thornburgh.” Federal Reporter. [Publication information not discernible.] [Photocopy]

18. Polia, M. and A. Bianchi. “Ethnological Evidences and Cultural Patterns of the Use of Trichocereus Pachanoi B.R. among Peruvian Curanderos.” Integration, Journal for Mind-Moving Plants and Culture, no. 1 (1991).

[Photocopy]

19. Sharon, Douglas. “The San Pedro Cactus in Peruvian Folk Healing.” In Flesh of the Gods: The Ritual Use of Hallucinogens, edited by Peter T. Furst, 114–135. New York: Praeger Publishers, 1972.

[Photocopy; brief marginalia]

20. Sharon, Douglas G. and Christopher B. Donnan. “The Magical Cactus: Ethnoarchaeological Continuity in Peru” [Article is part of a larger work, publication information is not discernible.] [Photocopy]

21. Trout, K., comp. Sacred Cacti and Some Selected Succulents: Botany, Chemistry, Cultivation and Utilization. Trout and Friends, 1997. [Article is excerpted from one chapter of a larger work.]

[Photocopy]

22. Trout, K., comp. Summary of the Occurrence of Mescaline. Trout and Friends, 1997. [Some of publication information is not discernible.]

[Photocopy]

4/12/2012 35

23. Trout, K., comp. “Trout’s Notes on Mescaline.” In Sacred Cacti and Selected Succulents. Trout and Friends, 1997.

[Reprint; document appears to be an unprinted version of a large work.]